Keyword: Procter & Gamble
Forget the charts and graphs. Lead with your heart. That’s the message from Attila Cansun, a chief marketing officer at the newly rebranded P&G Health.
P&G, the packaged goods giant that bought Merck KGaA’s consumer unit, is out in force at Lions Health. Is that a message for rivals?
As Lions Health wrapped up another year, attendees sifted their notes and pulled out a few common threads. Here are the ones we gathered.
P&G already has already bought one OTC unit from Big Pharma this year. But with BMS’s Upsa unit potentially up for sale, could it go for another?
Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.
Don't lose all hope for a Pfizer consumer health sale. Procter & Gamble is still at the negotiating table, CNBC’s David Faber reports.
Media agency Hearts & Science picked up Amgen’s estimated $350 million media account. The review included the retention of Amgen’s HCP business.
Novartis' soon-to-be-ex CEO Joe Jimenez has nailed at least one new job: board member at P&G, courtesy of a proxy fight at the consumer giant.
GSK and Reckitt Benckiser have already declared interest in Pfizer’s consumer health unit. But they likely won’t be alone when bidding kicks off.
There’s a new spokescharacter lurking around for Prevacid24. The animated ball of fire with a mischievous glint in his eye is the Lurker.